AbbVie (ABBV) Tops Q2 EPS by 2c, Offers FY Guidance
Get Alerts ABBV Hot Sheet
Join SI Premium – FREE
AbbVie (NYSE: ABBV) reported Q2 EPS of $1.42, $0.02 better than the analyst estimate of $1.40. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.92 billion.
GUIDANCE:
AbbVie sees FY2017 EPS of $5.44-$5.54, versus the consensus of $5.53.
For earnings history and earnings-related data on AbbVie (ABBV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA: working with AbbVie (ABBV) to identify, investigate and remove suspected counterfeit Botox products found in the US
- Acme United (ACU) Misses Q1 EPS by 20c
- PPG Industries (PPG) Reports In-Line Q1 EPS, offers outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!